Press "Enter" to skip to content

Chinese Fund Managers Dumping Biotech Stocks Amid Vaccine Scandal

Last updated on September 24, 2018

Chinese fund managers have cut holdings and lowered the valuation of their biotech stocks in their portfolios in the wake of a fake vaccine scandal which spills over to become a sector-wide trust crisis.

 

To continue reading, please subscribe. For only $0.8 per day, you will get:

 

  • ORIGINAL & DATA-DRIVEN STORIES - We focus on the most important business events and the key trends in China's economy and financial markets, with details that you don't see elsewhere.
  • THE WIRE - An all-in-one platform with real-time updates of market-moving news and views sourced from a network of journalists, traders, brokers, analysts, etc. and from multiple reliable news outlets in mainland China. Here are some screenshots of our wire service.
  • DATA¬† - We provide data, including some high frequency data from government agencies, research institutes and industry bodies to help you get timely and detailed understanding of what is going on in China's economy and markets.
  • WEEKLY NEWSLETTER - A summary of the week's top news distilled into one email.

 

We highly value independence. Subscriptions by you and thousands of intelligent readers like you are extremely important for us!

FREE TRIAL cancel anytime

Already have an account? Sign In

 

 

Top